MANNKIND CORP's ticker is MNKD and the CUSIP is 56400P706. A total of 185 filers reported holding MANNKIND CORP in Q2 2022. The put-call ratio across all filers is 1.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,818,888 | +1.3% | 20,537,261 | -0.2% | 0.00% | 0.0% |
| Q2 2023 | $83,721,091 | -1.3% | 20,570,293 | -0.5% | 0.00% | -33.3% |
| Q1 2023 | $84,801,740 | -23.4% | 20,683,351 | -1.5% | 0.00% | 0.0% |
| Q4 2022 | $110,716,351 | +76.8% | 21,008,795 | +3.7% | 0.00% | +50.0% |
| Q3 2022 | $62,629,000 | -22.8% | 20,268,091 | -4.8% | 0.00% | -33.3% |
| Q2 2022 | $81,121,000 | +6.3% | 21,290,953 | +2.7% | 0.00% | +50.0% |
| Q1 2022 | $76,301,000 | -16.8% | 20,733,724 | -1.2% | 0.00% | 0.0% |
| Q4 2021 | $91,742,000 | -2.7% | 20,993,492 | -3.1% | 0.00% | -33.3% |
| Q3 2021 | $94,259,000 | -21.0% | 21,668,450 | -1.0% | 0.00% | 0.0% |
| Q2 2021 | $119,258,000 | +62.2% | 21,881,981 | +16.6% | 0.00% | +50.0% |
| Q1 2021 | $73,544,000 | +30.7% | 18,761,214 | +4.4% | 0.00% | 0.0% |
| Q4 2020 | $56,264,000 | +69.5% | 17,975,840 | +1.8% | 0.00% | +100.0% |
| Q3 2020 | $33,193,000 | +12.2% | 17,655,971 | +4.4% | 0.00% | 0.0% |
| Q2 2020 | $29,590,000 | +93.2% | 16,908,391 | +13.7% | 0.00% | 0.0% |
| Q1 2020 | $15,315,000 | -20.5% | 14,870,479 | -0.5% | 0.00% | 0.0% |
| Q4 2019 | $19,276,000 | +5.2% | 14,943,086 | +2.0% | 0.00% | 0.0% |
| Q3 2019 | $18,316,000 | +11.6% | 14,652,452 | +2.7% | 0.00% | 0.0% |
| Q2 2019 | $16,412,000 | -36.3% | 14,271,602 | +9.1% | 0.00% | 0.0% |
| Q1 2019 | $25,771,000 | +105.5% | 13,081,856 | +10.6% | 0.00% | 0.0% |
| Q4 2018 | $12,541,000 | -41.3% | 11,832,404 | +1.3% | 0.00% | 0.0% |
| Q3 2018 | $21,381,000 | +8.6% | 11,682,722 | +12.7% | 0.00% | 0.0% |
| Q2 2018 | $19,686,000 | +147.7% | 10,361,672 | +197.3% | 0.00% | – |
| Q1 2018 | $7,947,000 | -3.1% | 3,485,528 | -1.4% | 0.00% | – |
| Q4 2017 | $8,201,000 | +95.4% | 3,534,811 | +82.8% | 0.00% | – |
| Q3 2017 | $4,197,000 | +201.9% | 1,934,009 | +96.1% | 0.00% | – |
| Q2 2017 | $1,390,000 | -74.9% | 986,125 | -73.7% | 0.00% | – |
| Q1 2017 | $5,540,000 | – | 3,743,311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 180 WEALTH ADVISORS, LLC | 1,482,638 | $6,078,816 | 1.41% |
| 1492 Capital Management LLC | 536,725 | $2,200,573 | 1.36% |
| Parkman Healthcare Partners LLC | 1,474,098 | $6,043,802 | 1.31% |
| EMERALD ADVISERS, LLC | 3,635,209 | $14,904,357 | 0.72% |
| Avoro Capital Advisors LLC | 9,100,000 | $37,310,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,879,671 | $7,706,651 | 0.46% |
| SCOPIA CAPITAL MANAGEMENT LP | 694,961 | $2,849,340 | 0.27% |
| Bruce & Co., Inc. | 195,073 | $799,799 | 0.22% |
| SWAN Capital LLC | 28,850 | $118,285 | 0.11% |
| Woodline Partners LP | 1,834,280 | $7,520,548 | 0.10% |